Rock Springs Capital Management LP Crinetics Pharmaceuticals, Inc. Transaction History
Rock Springs Capital Management LP
- $3.22 Billion
- Q2 2024
A detailed history of Rock Springs Capital Management LP transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 289,400 shares of CRNX stock, worth $14.7 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
289,400
Previous 289,400
-0.0%
Holding current value
$14.7 Million
Previous $13.5 Million
4.31%
% of portfolio
0.4%
Previous 0.35%
Shares
1 transactions
Others Institutions Holding CRNX
# of Institutions
244Shares Held
78.2MCall Options Held
268KPut Options Held
197K-
Black Rock Inc. New York, NY6.23MShares$316 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.11MShares$310 Million2.95% of portfolio
-
Wellington Management Group LLP Boston, MA4.62MShares$234 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.51MShares$229 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.41MShares$224 Million0.02% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.73B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...